about
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug ...
Read More
10.21
-0.34
(-3.22%)
421.4K
XNAS Volume
XNAS 27 Jan, 2026 4:30 PM (EST)
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks have average quality, financial and technical momentum, indicating a mid range performer
View Similar
Embed DVM
Delcath Systems Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..